Michel Albert

#Habs fan in Boston| Family, Investing, Sports, Current events| Husband, Father, Brother, Son

[UMassVascular @UMassVascSurg]

18 years ago we burnt a hole in an endograft for a single renal artery to repair (turned down for open repair) her juxtarenal aneurysm. Fast forward-we are discharging patients POD 1 after 3 vessel arch with percutaneous femoral puncture & radial puncture. Absolute magic.

[Penumbra Vascular @PenVascular]

A growing body of Level 1 evidence continues to reinforce catheter-based therapy as a valuable approach for the treatment of pulmonary embolism #CAVT #STORMPE

[Robert A Lookstein MD, MHCDL @roblookstein]

Live @MountSinaiIR first ever RCT of MT+AC vs AC alone for Acute PE published. A giant step forward for the field. Thank you to @CircAHA and @PenVascular

[Penumbra, Inc. @penumbrainc]

Penumbra announces secondary results of the ground-breaking STORM-PE RCT at VIVA 2025. Read more here: https://t.co/7DrLNUf4AR.

#CAVT #MedTech #Innovation #STORMPE #RCT

[Penumbra Vascular @PenVascular]

US HCPs: Interested in the future of PE care? Join Drs. James Benenati, Suhail Dohad, Patrick Muck, Parag Patel, and Rachel Rosovsky on November 12th as they share evolving data & innovative approaches for PE management with #CAVT.

Register here: https://t.co/ePs0XBVgIu

[Robert A Lookstein MD, MHCDL @roblookstein]

STORM-PE finds mechanical thrombectomy superior to anticoagulation alone - Interventional News https://t.co/phQVDKyqGB

[Penumbra Vascular @PenVascular]

US HCPs: Just presented by @roblookstein at #TCT2025, first ever Level 1 Evidence on mechanical thrombectomy with #CAVT + AC versus AC alone. #STORMPE #RCT https://t.co/kO7AcUd6iD

Rx only. Risk: https://t.co/SILdiRZoH4 Clinical results may vary

[Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI @DrJayMohan]

Storm PE #TCT2025 first landmark RCT trial comparing @PenVascular mechanical thrombectomy for PE compared to OAC

⬇️2.3x reduction in RV/LV
⚡️29% relative risk reduction
💚🙏🏾Safe and effective despite new technology
🔜Future data from wearable monitor to be release

CDT now should be highly consider (if not already) for intermediate and higher PE

Excited for three coming trials which will tell us more: HI-PIETHO2, PEERLESS 2, PE-TRACT.

[Julio Farjat Pasos @Julio_Farjat]

#TCT2025

[Shikha Jha M.D.🫀 @Shikha_Cardio]

#LBCT The STORM PE trial
Mechanical Thrombectomy + AC vs AC alone in intermediate to high risk PE
🌟Successful decrement in PAP
🌟 Superior reduction in RV/LV ratio
🌟Comparative Safety Profile
#TCT2025 @TCTConference @TCTMD @crfheart 💙💫

[Shariq Shamim @ShariqShamimMD]

News2 score was used to cross over if clinical deterioration.

[Shariq Shamim @ShariqShamimMD]

#TCT2025 STORM-PE trial. Penumbra Thrombectomy vs AC alone for intermediate risk PE. Superior improvement in RV/LV ratio with Thrombectomy vs AC alone.

#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @MartyBLeon @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD @jedicath @kalazizimd @Dr_ibrahimHarbi @BakhshiHooman @chiragbavishiMD @CathWhisperer @aayshacader @caldera_99 @NishithChandra @EspicheCarlos @Julio_Farjat @hect2701 @a_h_ghoneem @stefan_harb @sabeedak1 @pkothapalliMD @evandrofilhobr @GiorgioMedranda @omendiz @mornei2011 @SrihariNaiduMD @KrutarthKPandya @pagingdr_rao @DocSavageTJU @ShariqShamimMD @Shoaib9702 @Sticchi_Alex @poojaotherwise @Tabaza @atunuguntla1 @ladyheart_md @yaqoub_lina @EZancanaroMD

[Michel Albert @MAlbert94]

@vsb_abs @DejahJudelson @AndresSchanzer @VascularSVS Congratulations, @AndresSchanzer!

[Penumbra Vascular @PenVascular]

US HCPs: Join Dr. Hoots and @arslanmd at #SIR to see two retrospective studies on real-world outcomes & resource utilization findings w/ #CAVT management of lower extremity venous thrombus and ALI.

Rx only. Risk: https://t.co/SILdiRZoH4 Clinical results may vary

[Michel Albert @MAlbert94]

I found some great items at SHEIN!
These items in my shopping cart are great. I highly recommend them to everyone!
https://t.co/THVJtFUiLW

[Penumbra Vascular @PenVascular]

US HCPs: ❗Research indicates autotransfusion of unwashed blood for trauma patients is not as beneficial as you may think and is not widely accepted as the frontline therapy. Read more here: https://t.co/P54a6V95DX #TheCompletePEStory

[John Moriarty @JonnyMoriarty]

STRIKE-PE trial data drop: Impressive improvements in QOL post PE-intervention. Thx patients and investigators on 3 continents, more to come soon! https://t.co/ieBRatvQTi. @JVIRmedia @SIRspecialists @PERTConsortium @uclaVIR @UCLAPulmVasc @UCLAHealth

[Penumbra Vascular @PenVascular]

US HCPs: Congratulations to @JayMathewsMD at @ManateeMemorial on this bilateral PE thrombectomy w/ a 10-minute device time!⚡Lightning Flash 2.0, next-gen software for the treatment of PE. #CAVT #GallopMode

Rx only. Risk info: https://t.co/SILdiRZoH4 Clinical results may vary

[Penumbra Vascular @PenVascular]

US HCPs: Listen to Dr. Frank Arko talk about improving ALI outcomes using an endovascular first approach with #LightningBolt7. #CAVT
 
Rx only. Risk info: https://t.co/SILdiRZWwC Clinical results may vary

[@PatrickMuckMD @patrickmuckmd]

Leaving 1st generation thrombectomy in the past. We had the honor of being First In Man, again, for Penumbra Flash 2.0! With new improved simplicity of clot detection and even better blood saving technology, Flash 2.0 is State of the Art thrombus removal thrombectomy. #CAVT